CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Study ID
NCT07623655
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to evaluate the efficacy of the treatment with approved CAR-T cells in Italy in pediatric and adult patients with acute B-cell lymphoblastic leukemia. The main question it aims to answer is: which is the overall response rate in pediatric and adult patients with acute B-cell lymphoblastic leukemia treated with approved CAR-T cells? Data will be extracted from patients medical records.

Key Dates

First listed
Jun 3, 2026
Start date
Sep 1, 2026
Status verified
May 2026
Primary completion
Sep 1, 2029
Completion
Dec 30, 2029

Study Design

Enrollment
107 participants (estimated)

Arms

  • Arm: Patients with acute lymphoblastic leukemia treated with CAR-T cells
    Pediatric and adult patients with B-cell acute lymhoblastic leukemia treated with approved CAR-T cells in Italy

Primary Outcome Measure

Overall response [ Time Frame: 12 months ]

Central Contacts

Find similar trials

Nationwide
Leukemia (other) trialsOncology trialsBlood cancer trials

Related Studies